HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Beninati, C. Articles by Teti, G. Search for Related Content PubMed PubMed Citation Articles by Beninati, C. Articles by Teti, G.

Protective Immunization against Group B Meningococci Using Anti-Idiotypic Mimics of the Capsular Polysaccharide

Concetta Beninati^*, Simona Arseni, Giuseppe Mancuso^*, Walter Magliani, Stefania Conti, Angelina Midiri^*, Carmelo Biondo^*, Luciano Polonelli and Giuseppe Teti^1,*

^* Dipartimento di Patologia e Microbiologia Sperimentale, Università degli Studi di Messina, Messina, Italy; and Dipartimento di Patologia e Medicina di Laboratorio, Sezione di Microbiologia, Università degli Studi di Parma, Parma, Italy

Use of the serogroup B meningococcal capsular polysaccharide (MenB CP) as a vaccine is hampered by the presence of epitopes that cross-react with human polysialic acid. As non-cross-reactive, protective capsular epitopes have also been described, we set out to develop protein mimics of one of such epitopes using as a template a highly protective mAb (mAb Seam 3) raised against a chemically modified form of the MenB CP (N-Pr MenB CP). Using phage display, anti-idiotypic single-chain Ab fragments (scFvs) were obtained from spleen cells of mice immunized with the Seam 3 mAb. Two Seam 3-specific scFvs competed with N-Pr MenB CP for binding to either mAb Seam 3 or rabbit Abs present in typing sera. Moreover, in mice and rabbits the scFvs elicited the production of Abs reacting with both N-Pr MenB CP and whole meningococci, but not with human polysialic acid. These scFv-induced Ab responses were boostable and of the Th1 type, as shown by a predominance of IgG2a. In addition, passive immunization with sera from scFv-immunized animals partially protected neonatal mice from experimental infection with group B meningococci. In conclusion, we have produced anti-idiotypic scFvs that mimic a protective MenB CP epitope and may be useful in the development of an alternative group B meningococcal vaccine.

This article has been cited by other articles:

				C. Lo Passo, A. Romeo, I. Pernice, P. Donato, A. Midiri, G. Mancuso, M. Arigo, C. Biondo, R. Galbo, S. Papasergi, et al. Peptide Mimics of the Group B Meningococcal Capsule Induce Bactericidal and Protective Antibodies after Immunization J. Immunol., April 1, 2007; 178(7): 4417 - 4423. [Abstract] [Full Text] [PDF]

				C. Beninati, A. Midiri, G. Mancuso, C. Biondo, M. Arigo, E. Gerace, S. Papasergi, M. Gambuzza, M. Boretti, W. Magliani, et al. Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci J. Exp. Med., January 23, 2006; 203(1): 111 - 118. [Abstract] [Full Text] [PDF]

				I. H. Park, J. H. Youn, I.-H. Choi, M. H. Nahm, S. J. Kim, and J.-S. Shin Anti-Idiotypic Antibody as a Potential Candidate Vaccine for Neisseria meningitidis Serogroup B Infect. Immun., October 1, 2005; 73(10): 6399 - 6406. [Abstract] [Full Text] [PDF]